BioPharm International
October 08, 2019
Features
32
10
New guidance from FDA, including standards for interchangeability, is expected to speed development of biosimilars, but experts warn against oversimplifying risk to reduce costs.
October 08, 2019
Cover Story
32
10
Used with perfusion, alternating tangential flow and tangential flow filtration are redefining upstream efficiency.
October 01, 2019
From the Editor
32
10
Climbing out of a reputation hole can start with adopting a quality culture.
October 01, 2019
Features
32
10
Leveraging automation and a step-by-step approach are keys to success.
October 01, 2019
Regulatory Beat
32
10
Falsified documents and manipulated test results prompt warnings and investigations.
October 01, 2019
Ask the Expert
32
10
Data supporting the quality and safety of product must meet the ALCOA+ elements in order to avoid regulatory citations for data integrity issues, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
October 01, 2019
Features
32
10
The authors provide an introduction to aluminum adsorbed vaccines, review studies of antigen stability, and propose test methods for the analysis of aluminum vaccine release and stability analysis.
October 01, 2019
Features
32
10
Software systems can help validate pharmaceutical manufacturing and steer the most appropriate design of processes in the right direction.
October 01, 2019
Features
32
10
Advances in fill/finish for parenteral packaging address demands for efficiency and product safety.
October 01, 2019
Features
32
10
BioPharm International spoke with Marybeth Reynoso, senior director, early development strategic operations at PPD about the direction the industry is taking regarding the outsourcing of early development operations to contract research organizations (CROs).
October 01, 2019
Issue PDF
32
10
Click the title above to open the BioPharm International October 2019 issue in an interactive PDF format.